79066-03-8
Chemical Structure
PFM067
Synonym(s): DMHCA
- CAS No.: 79066-03-8
- Formula:C26H43NO2
- Molecular Weight:401.63
IUPAC Name: (R)-4-((3S,8S,9S,10R,13R,14S,17R)-3-hydroxy-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl)-N,N-dimethylpentanamide
InChIKey: NDGUBXOBXSPVHJ-LXVLQKCJSA-N
SMILES: C[C@@]12[C@](CC[C@]2([H])[C@H](C)CCC(N(C)C)=O)([H])[C@@]3([H])[C@@](CC1)([H])[C@@]4(C(C[C@H](CC4)O)=CC3)C
Biological Activity: PFM067, a potent and selective LXR agonist, specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. PFM067 has anti-inflammatory effects and can be used for the research of cholesterol homeostasis diabetes[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
PFM067 | 99.91% | PFM067, a potent and selective LXR agonist, specifically activates the cholesterol efflux arm of the LXR pathway without stimulating triglyceride synthesis. PFM067 has anti-inflammatory effects and can be used for the research of cholesterol homeostasis diabetes. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
